Affidavit of service of Nancy Gallinger sworn on 18-DEC-2018 on behalf of Plaintiff confirming service of the Notice of discontinuance upon Defendant by e-mail on 18-DEC-2018 filed on 18-DEC-2018

Discontinuance with Consent on behalf of Plaintiff filed on 18-DEC-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 17-DEC-2018 directing that "The case management conference scheduled for January 3, 2019 is adjourned." placed on file on 17-DEC-2018 Confirmed in writing to the party(ies)

Copy of Order (Amended) dated 17-DEC-2018 rendered by Mandy Aylen, Prothonotary placed on file. Original filed on Court File No. T-401-18

Ottawa 17-DEC-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Direction and Order to issue held by way of Conference Call in camera Duration per day: 17-DEC-2018 from 11:02 to 11:04 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 2min Appearances: Erin Creber 613 786 0222 representing Hoffmann-La Roche Ltd Ms. Dureen and Ms. Hitchman 1 416 777 2204 representing Pfizer Comments: DARS back up not used. Heard together with Court files T-401-18, T-869-17 T-876-17 and T-1270-17 Minutes of Hearing entered in Vol. 1013 page(s) 388 - 389 Abstract of Hearing placed on file

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 13-DEC-2018 directing that A case management conference shall be held, by teleconference, on Monday, December 17, 2018 at 11:00 am (Eastern). placed on file on 13-DEC-2018

Letter from parties dated 12-DEC-2018 Requesting a short CMC with parties to discuss outstanding issues received on 12-DEC-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 05-DEC-2018 directing that On the consent of the parties, the deadline for service and filing of Pfizer's confidentiality order motion record and proposed timetable for the motion is extended to December 21, 2018. placed on file on 05-DEC-2018

Letter from Pfizer Canada dated 04-DEC-2018 further to the direction of the Court Aylen, P dated November 30, 2018 received on 04-DEC-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 03-DEC-2018 directing that The issue of any page limit for expert reports shall be deferred to a later date, following the determination on the motion regarding the number of expert reports. In that regard, the parties shall, by no later than 10 days following the date of determination of the motion regarding the number of expert reports, provide the Court with a status update on this issue. The Court acknowledges the parties¿ submissions regarding the ¿skinny label¿ issue and how it should be addressed at trial. The Court will not issue any further direction on this issue at this time. Genentech may raise any concerns it has regarding this issue as the trial approaches for consideration by the Trial Judge. placed on file on 03-DEC-2018

Acknowledgment of Receipt received from Plaintiff with respect to Direction (ID.204) placed on file on 30-NOV-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 30-NOV-2018 directing that "The Court is not presently satisfied, based on Pfizer's submission in its letter dated November 29, 2018, that the highlighted information in the Court¿s Order dated November 22, 2018 constitutes confidential information warranting protection. Moreover, Genentech and LaRoche do not consent to such information being treated as confidential. Accordingly, should Pfizer continue to seek to have the highlighted information treated as confidential, Pfizer shall, by no later than December 10, 2018, serve and file a formal motion for a confidentiality order in relation to such information, together with a proposed timetable (derived in consultation with Genentech and LaRoche) for the perfection of the motion and the availability of the parties for the hearing of the motion (assuming it is not a motion in writing). The Court shall continue to maintain the highlighted information on a confidential basis pending the outcome of the motion or until December 11, 2018 if no motion is filed." placed on file on 30-NOV-2018 Confirmed in writing to the party(ies)

Sealed envelope pursuant to Order of the Court dated Feb 6, 2018 on behalf of Pfizer Received on 29-NOV-2018

Letter from Hoffmann-La Roche Limited dated 26-NOV-2018 furhter to the Courts direction dated Novemvber 22, 2018. received on 26-NOV-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 28-NOV-2018 directing that A case management conference shall be held, by teleconference, on January 3, 2019 at 9:00 am (Eastern). placed on file on 28-NOV-2018

Copy of Direction of the Court (Aylen, P) dated November 22, 2018 placed on file on 22-NOV-2018 Original filed on Court File No. T-401-18

Copy of Order dated 22-NOV-2018 rendered by Mandy Aylen, Prothonotary placed on file. Original filed on Court File No. T-401-18

Copy of CONFIDENTIAL ORDER dated 22-NOV-2018 rendered by Mandy Aylen, Prothonotary placed on file. Original filed on Court File No. T-402-18

Memorandum to file from Kathy Craigie dated 20-NOV-2018 Parties provided draft orders, further to the motions to compel heard on November 6, 2018. Draft orders forwarded to the Court. Parties were asked to provide mutual dates of availability for a CMC in the month of January 2019. placed on file.

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 19-NOV-2018 directing that "On the consent of the parties, the parties shall serve and file any motions for leave to file more than five expert reports by January 14, 2019. The delivery of responding and reply motion records shall be in accordance with the timelines prescribed by Rule 369. On the consent of the parties, the deadline for service of responding fact witness affidavits and will say statements shall be October 1, 2019." placed on file on 19-NOV-2018 Confirmed in writing to the party(ies)

Letter from Pfizer dated 16-NOV-2018 with consent of Hoffmann-La Roche further to the Courts direction dated November 2, 2018 received on 16-NOV-2018

Letter from Pfizer dated 16-NOV-2018 in relation to the Trial Management Conference. Counsel has provided a seperate letter regarding items b) and c)of the November 2, 2018 direction of the Court (Aylen, P). This letter is to advise of one additional issue that was discussed by the parties after the trial managment conference received on 16-NOV-2018

Certified French language Translation of Public Order rendered on 19-SEP-2018 by Mandy Aylen, Prothonotary filed on 13-NOV-2018 pursuant to s. 20 of the Official Languages Act. entered in J. & O. Book, volume 1391 page(s) 275 - 286

Memorandum to file from Kathy Craigie dated 06-NOV-2018 Motions to compel heard on November 6, 2018. Please see abstract in T-401-18 (id 211) for hearing information placed on file.

Letter from Hoffmann-La Roche dated 05-NOV-2018 Re: Motion to compel Nov 6 and Nov 7 with confidential attachment. - Confidential attachment placed in V annex received on 05-NOV-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 02-NOV-2018 directing that Further to the trial management conference held November 2, 2018: (a) The commencement of the trial will not be moved to August 2019. The trial hearing dates will remain as presently scheduled, with the exception that the Court will schedule one additional hearing day for closing arguments (one half day per party) to be held shortly after the conclusion of the trial on a date to be set by the Trial Judge in consultation with the parties. (b) Should any party seek to rely on more than five expert reports, a formal motion must be brought. In that regard, the parties shall meet and confer to discuss the timing of any such motions and shall provide a proposed schedule for the perfection of any such motions by no later than November 16, 2018. (c) The parties shall meet and confer to discuss a date for delivery of any responding fact witness affidavits and any will say statements (for those fact witnesses not providing an affidavit) and shall provide the Court with a proposed timetable for same by no later than November 16, 2018. (d) The parties shall meet and confer to discuss a reasonable page limit for expert reports. In the event that the parties are unable to reach an agreement, the parties shall, by no later than November 30, 2018, provide their respective submissions on this issue for the Court¿s consideration. (e) The parties shall meet and confer to discuss the ¿skinny label¿ issue and how best to address the issue at trial. The parties shall provide the Court with a status update on this issue by November 30, 2018. (f) The Trial Judge will leave open the possibility of hearing any motions for leave to file reply expert evidence in advance of the commencement of trial, rather than as part of the trial itself. (g) Genentech and LaRoche shall, by no later than November 5, 2018, produce to counsel for Pfizer the redacted documents (as addressed at the trial management conference) in electronic format on a counsel¿s and expert¿s eyes only basis. Pfizer shall, by no later than December 7, 2018, provide the Court with a status update on its review of the redactions and whether any motions are anticipated regarding the propriety of the redactions. placed on file on 02-NOV-2018

Ottawa 02-NOV-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Direction to follow held by way of Conference Call in chambers Duration per day: 02-NOV-2018 from 12:30 to 01:09 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 39min Appearances: Warren Sprigings 416 938 2273 representing Pfizer Meghan A. Dureen and Carol Hitchman 416 777 2204 representing Pfizer Tony Creber, John Norman and Adam Heckman 613 786 0140 representing Hoffmann-La Roche Comments: DARS back up used. Heard together with Court files T-401-18, T-402-18, T-869-17, T-876-17, T-1270-17 For complete set of minutes please refer to Volume 1009 page 333-338 TMC was heard before Justice Manson and Madam Aylen Minutes of Hearing entered in Vol. 1009 page(s) 339 - 340 Abstract of Hearing placed on file

Letter from Genentech dated 02-NOV-2018 items to address at TMC received on 02-NOV-2018

Letter from Pfizer Canada dated 01-NOV-2018 items to discuss at TMC received on 01-NOV-2018

Memorandum to file from Melissa Pilon dated 02-NOV-2018 motion Record on behalf of Hoffmann- Laroche and Genetech and usb key filed in T-401-18 placed on file.

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of doc. 61 upon all parties by email on consent on 01-NOV-2018 filed on 01-NOV-2018

Sealed envelope pursuant to Protective Orders on behalf of Defendant (Pfizer) purporting to contain electronic version of Responding Motion Record re: motions to compel answers from discoveries (hard copy filed in T-401-18) Filed on 01-NOV-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 25-OCT-2018 directing that A trial management conference shall be held on November 2, 2018 at 12:30 pm (Eastern) to address the issues raised in Pfizer¿s letter dated October 22, 2018. placed on file on 25-OCT-2018

Letter from Pfizer Canada dated 24-OCT-2018 in response to Genentechs Oct 23 letter received on 24-OCT-2018

Letter from Genentech dated 23-OCT-2018 In response to the Courts request for availability received on 23-OCT-2018

Letter from Pfizer dated 22-OCT-2018 Requesting a Trial Management Conference received on 22-OCT-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of Doc.59 upon Plaintiff by email on 17-OCT-2018 filed on 17-OCT-2018

Sealed envelope pursuant to ID#175 and ID#176 on behalf of Defendant purporting to contain ELECTRONIC MOTION TO COMPEL GENENTECH, INC AND HOFFMANN-LA ROCHE LIMITED TO PROVIDE ANSWERS TO REFUSED QUESTIONS (1 COPY ONLY SENT TO OTT) Filed on 17-OCT-2018

Memorandum to file from Ottawa dated 17-OCT-2018 A USB was received today containing the plaintiffs' motion to compel (Docs. 60, 64 in T-401-18) placed on file.

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 15-OCT-2018 directing that The parties are permitted to file their motion materials as proposed in Mr. Camenzind¿s letter dated October 15, 2018. placed on file on 15-OCT-2018

Letter from parties dated 15-OCT-2018 regarding the upcoming motion to compel - seeking directions regarding the number of copies of motion records received on 15-OCT-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 09-OCT-2018 directing that On the consent of the parties, the following timetable shall apply to the upcoming refusals motions: (a) The parties shall exchange written representations and charts of outstanding questions that will be pursued on refusals motions by October 16, 2018 at 11:00 pm (Eastern). (b) The parties shall serve and file moving motion records by October 17, 2018. (c) The parties shall serve and file responding motion records by November 1, 2018, ensuring that a copy of their written representations and charts are emailed to CMT_Ottawa@cas-satj.gc.ca. (d) The hearing of the motions shall proceed as scheduled on November 6 and 7, 2018. The parties are reminded of the Court¿s Notice to the Parties and the Profession ¿ Case Management: Increased Proportionality in Complex Litigation Before the Federal Court dated June 24, 2015, which provides that: (i) questions should be answered unless clearly improper or prejudicial or would require the disclosure of privileged communication; (ii) refusals motions are limited to one hour per day of discovery of each party¿s representative; and (iii) potentially significant cost sanctions may be imposed against unsuccessful/unreasonable parties. The parties are accordingly highly discouraged from submitting hundreds of questions to the Court for determination on the refusals motions. placed on file on 09-OCT-2018

Letter from Hoffman-La Roche dated 09-OCT-2018 regarding the motion to compel. parties submit a timetable on consent and confirm the CMC may not be necessary received on 09-OCT-2018

Order (CONFIDENTIALITY) dated 05-OCT-2018 rendered by Mandy Aylen, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Defendant dated 01-OCT-2018 Result: THIS COURT ORDERS THAT: 1. The following definitions shall apply for the purpose of this Order: (a) Pfizer Canada Inc. is referred to as "Pfizer". Hoffmann-La Roche Limited is referred to a "Roche". Genentech, Inc. is referred to a "Genentech". Each of Pfizer, Roche and Genentech are referred to in the singular as a "Party" and together as "Parties". (b) "Document" has the same meaning as defined in Rule 222(1) of the Federal Court Rules. (...) 12. No costs are payable in respect of this Order. Filed on 05-OCT-2018 entered in J. & O. Book, volume 1386 page(s) 353 - 359 Interlocutory Decision

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 03-OCT-2018 directing that "Given the large number of refusals that remain at issue on the motion in T-1471-17, the Court is not prepared to allocate any portion of the hearing time to address the parties' separate issues in T-401-18 et al. As such, the parties shall forthwith provide their availability for a case management conference next week to address the issues raised in T-401-18 et al." placed on file on 03-OCT-2018 Confirmed in writing to the party(ies)

Letter from Defendant dated 01-OCT-2018 re: confidentiality orders received on 01-OCT-2018

Memorandum to file from Kathy Craigie Ottawa dated 01-OCT-2018 Counsel for the Defendant confirmed that the request made on behalf of the Plaintiff dated September 28th 2018 was not made on beahlf of all parties. placed on file.

Letter from Plaintiff dated 28-SEP-2018 re: steps leading up to refusals motions. request 15 min at the October 4th hearing in T-1471-17 to discuss received on 28-SEP-2018

Affidavit of service of Nancy Gallinger sworn on 26-SEP-2018 on behalf of the Plaintiffs (Hoffmann-La Roche Ltd. & Genentech Inc.) confirming service of document no. 56 upon the Defendant (Pfizer Canada Inc.) by e-mail on 26-SEP-2018 filed on 26-SEP-2018

Amended Reply to the Second Amended Statement of Defence on behalf of the Plaintiffs (Hoffmann La-Roche Ltd. & Genentech Inc.) Filed on 26-SEP-2018

Letter from Defendant dated 20-SEP-2018 in response to the letter from the Plaintiffs dated Sept 20, 2018 received on 20-SEP-2018

Letter from Plaintiff dated 20-SEP-2018 requesting the Court postpone the hearing of any refusals motions by parties from the currently scheduled dates of November 6 & 7, 2018. received on 20-SEP-2018

Order dated 19-SEP-2018 rendered by Mandy Aylen, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Directions of the Court dated 02-AUG-2018 Result: Public Order re: Pfizer seeking to bring a motion for summary judgment or summary trial in relation to this action. Filed on 19-SEP-2018 entered in J. & O. Book, volume 1384 page(s) 439 - 449 Interlocutory Decision

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of Second Amended Statement of Defence upon Defendant by email on 17-SEP-2018 filed on 17-SEP-2018

Second Amended Statement of Defence filed on 17-SEP-2018

Letter from Defendant dated 17-SEP-2018 advising that the Order (see direction dated September 4, 2018) does not contain any confidential information of the parties. received on 17-SEP-2018

Letter from Defendant dated 17-SEP-2018 re: trial dates. Scanned to P. Aylen. received on 17-SEP-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 04-SEP-2018 directing that The parties shall consult as to whether the Order contains any confidential information and reach an agreement in relation thereto. The parties shall, by no later than than September 17, 2018, advise the Court whether the Order contains any confidential information and if so, specify the exact information that needs to be redacted from the public version of the Order. placed on file on 04-SEP-2018

CONFIDENTIAL ORDER dated 04-SEP-2018 rendered by Mandy Aylen, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Special Case Result: CONFIDENTIAL Filed on 04-SEP-2018 entered in J. & O. Book, volume 1383 page(s) 73 - 83 Interlocutory Decision

Affidavit of service of Nancy Gallinger sworn on 28-AUG-2018 on behalf of Plaintiff confirming service of DOC. No. 49 upon Defendant by email on 28-AUG-2018 filed on 29-AUG-2018

Consent on behalf of Defendant to the Plaintiffs' Second Amended Statement of Claim filed on 29-AUG-2018

Second Amended Statement of Claim filed on 29-AUG-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 30-AUG-2018 directing that The Court has considered the submissions of the parties dated August 29, 2018 in relation to the reallocation of discovery time. The Court ordered the maximum duration of examinations for discovery at four days for corporate representatives and a half day per inventor and that if a named inventor was also produced as the corporate representative, a party would still have 1.5 days to examine that individual. This order was made based on four patents being at issue in the proceedings. Since that time, the claims related to the 596 Patent have been discontinued and as a result, there now remains only three patents at issue in these proceedings. While I would have found that Pfizer's entitlement to days of discovery should be reduced as a result of the discontinuance of the claims related to the 596 Patent, I am satisfied that there was a clear lack of communication and understanding between the parties as to the impact of the discontinuance on the discovery days and that Pfizer proceeded to allocate its discovery time based on its understanding/misunderstanding. I find that in the circumstances, it would be prejudicial to not permit Pfizer to continue with the original amount of discovery time allocated. In making this finding, I would also stress that these files have been plagued by a lack of cooperation and communication between the parties which has resulted in a number of disputes requiring the Court's intervention, this being yet another one. Had the parties properly communicated regarding this issue before the discoveries proceeded, this issue could have been avoided. Accordingly, Pfizer is entitled to further discovery as requested in its letter dated August 29, 2018. placed on file on 30-AUG-2018

Letter from Defendant dated 29-AUG-2018 Further to the Courts direction dated August 22, 2018 Counsel encloses previous correspondence between parties received on 29-AUG-2018

Letter from Counsel for the Plaintiff, Hoffmann-La Roche Limited and Genentech dated 29-AUG-2018 further to the Courts direction dated August 22, 2018. received on 29-AUG-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 29-AUG-2018 directing that On the consent of the parties, the Plaintiffs are granted leave to serve and file, by no later than August 31, 2018, a Second Amended Statement of Claim in each action in the form agreed to by the parties. Pfizer shall serve and file any amended Statement of Defence that makes amendments that are consequential to the amendment of the Plaintiffs¿ pleading by no later than September 17, 2018. Any further, non-consequential amendments that Pfizer may seek to make may be included in its amended pleading if on the consent of the parties or with leave of the Court, or by way of a further amendment at later point in time on the consent of the parties or with leave of the Court. placed on file on 29-AUG-2018

Letter from Plaintiff dated 28-AUG-2018 Further to the Courts direction dated August 22, 2018 received on 28-AUG-2018

Letter from Defendant, Pfizer Canada Inc dated 28-AUG-2018 Further to the direction of the Court (Aylen, P) dated August 22, 2018 received on 28-AUG-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 22-AUG-2018 directing that "The Court is in receipt of letters from both parties dated August 21, 2018. Genentech shall, by no later than August 24, 2018, provide to Pfizer a substantive response to Pfizer's letter dated August 9, 2018 regarding the reallocation of the day of corporate discovery arising from the discontinuance of claims related to the 596 Patent. If further discussions are to be held between the parties to address this issue, they shall be held by no later than August 28, 2018. The parties shall provide the Court with a further status update on this issue by August 29, 2018. Counsel for Pfizer shall forthwith obtain instructions from Pfizer regarding the narrowing of the claims, the proposed amended pleasdings and a timetable for amended responding pleadings. There is no value in holding a case management conference at this time if Pfizer has no instructions in relation to these issues. The parties shall confer by telephone on these issues and provide the Court with a status report by no later than August 28, 2018." placed on file on 22-AUG-2018

Letter from Springings Law dated 21-AUG-2018 Springings Law responds that the counsel did not provide the letter for comment ahead of time and that the letter contained inaccurate information with respect to Pfizer's position on a number of issues. received on 21-AUG-2018

Communication to the Court from the Registry dated 23-AUG-2018 re: file sent to Court re: submissions on motion for summary dismissal

Letter from Gowling WLG dated 21-AUG-2018 Letter requesting the Case Management Judge's assistance in resolving minor administrative issues in the actions in T-401-18/T-402-18/T-1269-17. received on 21-AUG-2018

Solicitor's certificate of service on behalf of Defendant confirming service of doc.46 doc.47 upon Plaintiff by email on 22-AUG-2018 filed on 22-AUG-2018

Letter from Defendant dated 22-AUG-2018 PUBLIC SUBMISSIONS- further to our submissions dated August 9,2018 and in response to Plaintiff Hoffman-La Roche submissions pursuant to Direction dated August 2,2018 filed on 22-AUG-2018

Sealed envelope pursuant to Order dated May 1,2018 on behalf of Defendant purporting to contain Letter from defendant setting out Pfizer's reply submission to doc.43 pursuant to Direction dated August 2,2018 Filed on 22-AUG-2018

Affidavit of service of Nancy Gallinger sworn on 17-AUG-2018 on behalf of Plaintiff confirming service of doc. nos. 43 and 44 upon Defendant by email on consent on 17-AUG-2018 filed on 17-AUG-2018

Written Submissions (PUBLIC) on behalf of Plaintiff concerning whether the Defendant be permitted to file a motion for summary judgment filed on 17-AUG-2018

Written Submissions (CONFIDENTIAL) on behalf of Plaintiff concerning whether the Defendant be permitted to bring motion for summary judgment filed on 17-AUG-2018

Letter from Defendant dated 09-AUG-2018 providing submissions and the notice of motion for summary judgment further to the Court's direction dated August 2, 2018. received on 09-AUG-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 02-AUG-2018 directing that "Further to today's case management conference, Pfizer shall serve and file its proposed notice of motion and submissions regarding whether Pfizer should be permitted to bring a motion for summary dismissal by August 9, 2018, the Plaintiffs shall serve and file their responding submissions by August 17, 2018 and Pfizer shall serve any reply submissions by August 22, 2018." placed on file on 02-AUG-2018 Confirmed in writing to the party(ies)

Ottawa 02-AUG-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Directon to follow held by way of Conference Call in chambers Duration per day: 02-AUG-2018 from 09:30 to 09:50 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 20min Appearances: Mr. Creber, Mr. Norman, Mr. Camenzind, 613 786 0140 representing Plaintiff Mr. Sprigings, Ms. Dureen 416 938 2273 representing Defendant Comments: DARS not used, at the request of the Court Minutes of Hearing entered in Vol. 1003 page(s) 235 - 238 Abstract of Hearing placed on file

Letter from Plaintiff dated 01-AUG-2018 re: issues raised during CMC fixed for 9:30 a.m. on August 2, 2018 received on 01-AUG-2018

Copy of Order dated 01-AUG-2018 rendered by The Honourable Mr. Justice Manson placed on file. Original filed on Court File No. T-401-18

Toronto 20-JUL-2018 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Motion ex proprio motu Result of Hearing: Matter reserved held in Court Senior Usher: Anne Brzuchalski Duration per day: 20-JUL-2018 from 09:30 to 11:53 Courtroom : Courtroom No. 5-A - Toronto Court Registrar: Abigail Grimes Total Duration: 2h 23mins Appearances: Carol Hitchman / Meghan Dureen / Nathanial Dillonsmith 416-777-0888 representing Pfizer Canada Inc. Anthony Creber / Frederick Lussier / Justin Smith 613-233-1781 representing Genentech Inc., et al Comments: Parties are to provide the Court with what has been agreed upon and address any confidentiality issues on or before 25-JUL-2018 Matter heard together with T-876-17, T-1269-17, T-1270-17, T-401-18 & T-869-17 DARS Z006207 Minutes of Hearing entered in Vol. 1003 page(s) 216 - 222 Abstract of Hearing placed on file

Letter from Defendant dated 01-AUG-2018 further to the direction of the Court (Aylen, P) dated July 11, 2018 received on 01-AUG-2018

Letter from Genentech, Inc. dated 27-JUL-2018 further to motion heard 20-JUL-2018 and Pfizer's letter dated 27-JUL-2018 received on 27-JUL-2018

Letter from Pfizer Canada Inc. dated 27-JUL-2018 further to the motion heard 20-JUL-2018 with attachments received on 27-JUL-2018

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 25-JUL-2018 directing that further to correspondence from the parties, the extension of time is granted placed on file on 25-JUL-2018 Confirmed in writing to the party(ies)

Letter from Pfizer Canada Inc. dated 25-JUL-2018 requesting an extension of time to provide the draft Order to the Court further to the motion heard 20-JUL-2018, on behalf of the parties received on 25-JUL-2018

Confidential Pfizer's Chart by Categories received at hearing on 20-JUL-2018

Letter from Defendant dated 19-JUL-2018 further to Direction of Manson, J. dated 17-JUL-2018. Copy of letter and confidential enclosures placed in V annexes. received on 19-JUL-2018

Oral directions received from the Court: The Honourable Mr. Justice Manson dated 17-JUL-2018 directing that The Court requires that based on the parties' submissions of July 13 and July 16, 2018, Pfizer is to advise the Court what, specifically, remains in issue with respect to their motions for document production, by July 19, 2018. Any production determined to be unnecessary or irrelevant will attract significant cost consequences, payable forthwith. Similarily, Genentech shall advise the Court of any further productions that will be made in response to Pfizer's outstanding requests and when, if any further productions are to be made, those productions will be made. Any refusals found to be unjustified will also attract significant cost consequences, payable forthwith. placed on file on 17-JUL-2018 Confirmed in writing to the party(ies)

Letter from Hoffmann-La Roche Ltd dated 19-JUL-2018 Pursuant to the direction of the Court (Manson, J) dated July 17, 2018 received on 19-JUL-2018

Communication to the Court from the Registry dated 18-JUL-2018 re: file sent to Court re: CMC fixed for August 2, 2018

Acknowledgment of Receipt received from all parties with respect to direction of the Court (Aylen, P) dated July 18, 2018 placed on file on 18-JUL-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 18-JUL-2018 directing that A case management conference shall be held, by teleconference, at 9:30 am (Eastern) on August 2, 2018 placed on file on 18-JUL-2018

Letter from The Plaintiff, Hoffmann-La Roche Limited dated 17-JUL-2018 available for CMC on August 2, 2018 in the morning received on 17-JUL-2018

Letter from The Defendant (Pfizer Canada) dated 17-JUL-2018 Pursuant to the Courts Direction of July 11, 2018. Counsel provides dates of availability for a Case Management Conference received on 17-JUL-2018

Letter from Pfizer Canada dated 13-JUL-2018 Status update pursuant to the Order of the Court (Aylen, P) dated June 22, 2018. Copy of letter and confidential enclosures placed in V annexes. received on 13-JUL-2018

Affidavit of service of Nancy Gallinger sworn on 13-JUL-2018 on behalf of Plaintiff confirming service of Doc. No. 41 Amended Reply upon Defendant by e-mail on 13-JUL-2018 filed on 13-JUL-2018

Amended Reply with proof of service upon Defendant on 13-JUL-2018 filed on 13-JUL-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 11-JUL-2018 directing that " The Court is in receipt of Pfizer¿s letter dated July 9, 2018. Unfortunately, the Court is not available for a case management conference on the dates proposed by the parties. The Court is available on August 1 (afternoon only), August 2 and August 3, 2018. The parties shall forthwith advise as to their availability on those dates. The Court notes that Pfizer proposes serving its evidence on the motion for summary judgment/summary trial on July 30, 2018. Pfizer is at liberty to serve its evidence by that date if it so choses, however the balance of the timetable will remain open for consideration at the case management conference, as well whether the motion can be brought in light of Rule 213." placed on file on 11-JUL-2018 Confirmed in writing to the party(ies)

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of Amended Statement of Defence filed July 3, 2018 upon Plaintiff by email on consent on 03-JUL-2018 filed on 03-JUL-2018

Amended Defence filed on 03-JUL-2018

Letter from Defendant dated 09-JUL-2018 advising that all parties have discussed the scheduling of Pfizer's motion for judgment. A timetable is included and mutual availability for a cmc if one is required. received on 09-JUL-2018

Letter from Hoffmann-La Roche dated 20-JUN-2018 re: proposed motion for further documents from Pfizer received on 20-JUN-2018

Copy of Order dated 22-JUN-2018 rendered by Mandy Aylen, Prothonotary placed on file. Original filed on Court File No. T-401-18

Ottawa 22-JUN-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Order to follow held by way of Conference Call in camera Duration per day: 22-JUN-2018 from 01:00 to 01:36 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 37min Appearances: Ms. Hitchman, Mr. Sprigings, Mr. Dillonsmith, 416 777 2204 representing Pfizer Canada Mr. Creber, Mr. Norman, Mr. Lussier 613 786 0140 representing Hoffmann-La Roche Comments: DARS back up used. Justice Manson particpated in the CMC. Heard together with T-401-18, T-869-7, T-876-17, T-1269-17 and T-1270-17 For complete set of minutes please see v. 1000 pg. 452-457 Minutes of Hearing entered in Vol. 1000 page(s) 458 - 459 Abstract of Hearing placed on file

Letter from Hoffmann-La Roche Limited dated 22-JUN-2018 In advance of the CMC, with respect to Pfizer¿s motion for further and better affidavit of documents. received on 22-JUN-2018

Letter from The Defendant, Pfizer Canada Inc dated 21-JUN-2018 re: Amended Statement of Claim and a draft notice of Motion for Judgment. received on 22-JUN-2018

Letter from Pfizer Canada dated 20-JUN-2018 In response to the letter from Counsel, Genentech Inc. dated June 19, 2018, regarding Pfizer`s motion currently scheduled for July 6, 2018. received on 21-JUN-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 20-JUN-2018 directing that A case management conference shall be held on Friday, June 22, 2018 at 1:00 pm (Eastern) to address the issues raised in Mr. Lussier¿s letter dated June 19, 2018. Both Case Management Judge Aylen and Justice Manson will be presiding. placed on file on 20-JUN-2018

Letter from Pfizer dated 20-JUN-2018 Pursuant to the Direction of the Court of today¿s date, this is to advise that counsel for Pfizer are available all day on Friday June 22, 2018 for a case management conference. received on 20-JUN-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 20-JUN-2018 directing that Pfizer shall, by no later than 9:00 am (Eastern) on June 21, 2018, provide a letter to the Court addressing the concerns raised by Genentech/Roche in their letter dated June 19, 2018. Pfizer shall also, by no later than 4:00 pm today, provide its availability for a case management conference on Friday to address this issue (should the Court determine that a case management conference is needed). placed on file on 20-JUN-2018

Letter from Hoffmann-La Roche dated 19-JUN-2018 With respect to the motions for documents by Pfizer Canada Inc. Counsel confirms the scope of the motion discussed during the CMC is significantly different from what Pfizer now seeks to do. received on 19-JUN-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 11-JUN-2018 directing that Further to the case management conference held June 11, 2018: (a) The parties shall settle all discovery dates by June 15, 2018. (b) With respect to Genentech¿s pending motion: a. Pfizer shall serve a list of its category 4 and 5 documents over which it claims privilege (with the exception of those that are communications with external counsel) by June 15, 2018. b. Genentech shall serve and file its complete moving record by June 22, 2018. c. Pfizer shall serve and file its responding motion record by June 29, 2018. (c) With respect to Pfizer¿s pending motion: a. Pfizer shall serve and file its complete moving record by June 18, 2018. b. Genentech shall serve and file its responding record by June 27, 2018. (d) Both Pfizer¿s and Genentech¿s motion shall be heard on July 6, 2018 from the Federal Court in Ottawa commencing at 1:30 pm (Eastern) for a maximum duration of three hours. placed on file on 11-JUN-2018

Ottawa 11-JUN-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: direction to follow held by way of Conference Call in chambers Duration per day: 11-JUN-2018 from 03:00 to 03:47 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 47min Appearances: Mr. Creber and Mr. Lussier 613 786 0140 representing Plaintiff Mr. Sprigings, Ms. Hitchman and Mr. Dillonsmith 1 416 777 2273 representing Defendant Comments: DARS back up not use at the request of the Court. Heard together with T-401-18, T-869-17, T-876-17, T-1269-17 and T-1270-17 for complete set of minutes please refer to the V. 1000, pgs 24 to 29 of the Minutes of hearing book. Minutes of Hearing entered in Vol. 1000 page(s) 221 - 222 Abstract of Hearing placed on file

Memorandum to file from Kathy Craigie dated 11-JUN-2018 "We confirm that the Defendant, Pfizer Canada Inc. does not have concerns regarding the confidentiality of the DARS recording of May 29, 2018 and the recording can be made public." -this information was forwarded to the Court, who confirmed a formal direction would not issue, and that a notation of the file is acceptable. placed on file.

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 05-JUN-2018 directing that A case management conference shall be held, by teleconference, on June 11, 2018 at 3:00 pm (Eastern) to address the schedule for the motions for further and better affidavits of documents. The parties shall, in advance of the case management conference, discuss by telephone the parties' respective timetables to determine whether a consensus can be reached for the timing of both motions. However, the Court will be looking to schedule the hearing of both motions as soon as possible so as to preserve the existing discovery schedule. Complete moving motion records should be delivered by no later than the end of next week and if the motions are to be heard orally, the proposed timetable shall not include a right of reply. placed on file on 05-JUN-2018

Letter from Pfizer Canada dated 04-JUN-2018 In response to the letter dated June 4, 2018 on behalf of Hoffmann-La Roche received on 04-JUN-2018

Letter from Hoffmann-La Roche Limited dated 04-JUN-2018 further to the scheduling order dated May 29, 2018, where the Court reqeusted that counsel advise if a motion for further and better affidavits of documents would be required. Counsel confirms that Pfizer has not yet provided clarification or further information with related to the documents requested. Because cousel does not have a response as to why the documents have not been produced, counsel is enclosing Notices of Motions. received on 04-JUN-2018

Affidavit of service of Nancy Gallinger sworn on 31-MAY-2018 on behalf of the Plaintiffs confirming service of document no. 37 upon Defendant by e-mail on 31-MAY-2018 filed on 31-MAY-2018

Amended Statement of Claim filed on 31-MAY-2018

Copy of Order dated 29-MAY-2018 rendered by Mandy Aylen, Prothonotary concerning Copy of Order dismissing motions to strike in both T-401-18 and T-402-18 placed on file. Original filed on Court File No. T-401-18

Ottawa 29-MAY-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Motion Doc. No. 9 on behalf of Defendant Result of Hearing: Matter dismissed held in Court by way of video conference Senior Usher: Roger Heroux Duration per day: 29-MAY-2018 from 02:00 to 02:55 Courtroom : Videoconference Room 703 - 7th Floor - Thomas D'Arcy McGee Bldg. - Ott Court Registrar: Kathy Craigie Total Duration: 1h 55min Appearances: Mr. Creber and Mr. Camenzind 1 613 786 0140 representing Plaintiff Ms. Hitchman and Ms. Dureen 416 777 2204 representing Defendant Comments: Heard together with T-401-18. For complete set of minutes please refer to the minutes of hearing book Vol. 999 page 139-145 MINUTES AND AUDIO OF THIS HEARING TO REMAIN CONFIDENTIL UNTIL CONFIRMATION IS RECEIVED ON BEHALF OF THE DEFENDANT. Minutes of Hearing entered in Vol. 999 page(s) 146 - 152 Abstract of Hearing placed on file

Bill of costs of Plaintiff received on 29-MAY-2018

Letter from Plaintiff dated 29-MAY-2018 VIA EMAIL - attaching Bill of Costs received on 29-MAY-2018

Bill of costs of Defendant received on 29-MAY-2018

Copy of Scheduling Order - Amendment No. 1 dated 29-MAY-2018 rendered by Mandy Aylen, Prothonotary placed on file. Original filed on Court File No. T-401-18

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of document no. 35 upon all parties by e-mail (on consent) on 23-MAY-2018 filed on 23-MAY-2018

Written Supplemental Representations on behalf of Defendant concerning Motion Doc. No. 9 filed on 23-MAY-2018

Affidavit of service of Nancy Gallinger sworn on 25-MAY-2018 on behalf of Plaintiff confirming service of doc. no. 33 upon Defendant by email on consent on 25-MAY-2018 filed on 25-MAY-2018

Written Supplemental Submissions on behalf of Plaintiff concerning Motion Doc. No. 9 filed on 25-MAY-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 23-MAY-2018 directing that The parties shall be prepared to address the issue of costs at the hearing of the motions to strike on May 29, 2018 and shall provide the Court with a detailed bill of costs at the hearing.¿ placed on file on 23-MAY-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 17-MAY-2018 directing that "Pfizer's motion to strike shall be heard on May 29, 2018, for 2 hours commencing at 2:00 pm (Eastern) from the Federal Court in Ottawa, with video-conferencing from the Federal Court in Toronto. Pfizer shall serve and file its supplemental submissions by May 23, 2018 and Genentech shall serve and file its supplemental submissions by May 25, 2018." placed on file on 17-MAY-2018

Ottawa 17-MAY-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: direction to follow held by way of Conference Call Duration per day: 17-MAY-2018 from 02:01 to 02:50 Courtroom : Judge's Chambers - Ottawa Court Registrar: Chantal Mainville Total Duration: 49m Appearances: John Normam, Anthony Creber, Frederic Lussier 613-786-0140 representing Plaintiff Meghan A. Dureen, Carol Hitchman 416-777-2204 representing Defendant Comments: DARS not used at the request of the Court Minutes of Hearing entered in Vol. 998 page(s) 262 - 267 Abstract of Hearing placed on file

Letter from Defendant dated 17-MAY-2018 prividing a proposed schedule in advance of the case management conference. Scanned to P. Aylen. received on 17-MAY-2018

Letter from Plaintiff dated 17-MAY-2018 Proposed agenda on behalf of parties for CMC fixed for 2 pm today, May 17, 2018 received on 17-MAY-2018

Acknowledgment of Receipt received from all parties with respect to Direction of the Court (Aylen, P) dated May 14, 2018 placed on file on 14-MAY-2018

Letter from Defendant dated 13-MAY-2018 In response to the Oral direction of the Court (Aylen, P) dated April 30, 2018 received on 14-MAY-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 14-MAY-2018 directing that A case management conference shall be held, by teleconference, on May 17, 2018 at 2:00 pm (Eastern). The parties shall, in advance of the case management conference, discuss the additional concerns raised by Pfizer regarding the proposed amended pleadings and be prepared to address them at the case management conference. placed on file on 14-MAY-2018

Letter from Plaintiff dated 11-MAY-2018 On April 30, 2018 the Court (Aylen, P) adjourned Pfizer's motion to strike in these actions, and requested parties attempt to resolve this motion via amendments to the statement of claim. received on 11-MAY-2018

Letter from Plaintiff dated 03-MAY-2018 Further to the direction dated April 24, 2018. Wherein parties are to provide the Court with a proposed confidentiality order related to the Defendant's section 6.08 motion The parties request an extension to Tuesday May 8, 2018. received on 03-MAY-2018

Letter from Plaintiff dated 02-MAY-2018 Further to the Order of the Court (Aylen, P) dated April 23, 2018. -proposed timetable received on 02-MAY-2018

Acknowledgment of Receipt received from all parties with respect to Order of the Court (Aylen, P) dated May 1, 2018 placed on file on 01-MAY-2018

ORDER (PROTECTIVE ORDER) dated 01-MAY-2018 rendered by Mandy Aylen, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion in writing Doc. No. 19 Result: Counsel for the Plaintiffs advised they are agreeable to the issuance of the Protective Order in the form proposed by the Defendant, with exception of paragraph 25 (Please see attached for terms of protective order) Filed on 01-MAY-2018 entered in J. & O. Book, volume 1367 page(s) 353 - 367 Interlocutory Decision

Copy of Letter from Sprigings dated 01-MAY-2018 placed on file on 01-MAY-2018 Original filed on Court File No. T-401-18

Ottawa 30-APR-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Motion Doc. No. 19 on behalf of Plaintiff Result of Hearing: Matter adjourned sine die Before the Court: Motion Doc. No. 9 on behalf of Defendant Result of Hearing: Matter reserved held in Court Senior Usher: Denis Gendron Duration per day: 30-APR-2018 from 09:30 to 10:15 Courtroom : Courtroom No. 702, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Kathy Craigie Total Duration: 45min Appearances: Anthony Creber, Frederic Lussier, Alexander Camenzind 613 233 1781 representing Plaintiff Meghan A Dureen and Carol Hitchman 416 777 0888 representing Defendant Comments: Heard together with T-401-18 DARS used Minutes of Hearing entered in Vol. 997 page(s) 1 - 5 Abstract of Hearing placed on file

Letter from Plaintiff dated 27-APR-2018 in response to the letter from the Defendant Counsel disagrees with Ms. Dureens letter dated April 27, 2018 received on 27-APR-2018

Letter from Defendant dated 27-APR-2018 with respect to the affidavits of documents and schedule one productions received on 27-APR-2018

Solicitor's certificate of service on behalf of Defendant confirming service of doc.30 and Book of Authorities upon Plaintiff by email on consent on 26-APR-2018 filed on 26-APR-2018

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 26-APR-2018 Sent directly to Presiding Judge

Motion Record in response to Motion Doc. No. 19 containing the following original document(s): 28 29 Number of copies received: 1 on behalf of Defendant filed on 26-APR-2018

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 19 filed on 26-APR-2018

Affidavit of Katie Krajacic sworn on 26-APR-2018 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 19 with Exhibits A-Q filed on 26-APR-2018

Copy of Scheduling Order dated 23-APR-2018 rendered by Mandy Aylen, Prothonotary placed on file. Original filed on Court File No. T-401-18

Ottawa 23-APR-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Scheduling order will issue held by way of Conference Call in chambers Duration per day: 23-APR-2018 from 01:00 to 01:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 35 min Appearances: Anthony Creber 613 786 0140 representing Plaintiff Frederick Lussier 613 786 0140 representing Plaintiff Warren Spriginings 416 777 2273 representing Defendant Carol Hitchman 416 777 2273 representing Defendant Meghan Dureen 416 777 2273 representing Defendant Comments: Heard together with T-401-18 for complete set of minutes, please refer to the v. 996 pages 355-360 of the minutes of hearing book. Minutes of Hearing entered in Vol. 996 page(s) 361 - 362 Abstract of Hearing placed on file

Motion Record containing the following original document(s): 26 Number of copies received: 1 on behalf of Plaintiff filed on 20-APR-2018

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 19 filed on 20-APR-2018

Motion Record containing the following original document(s): 24 Number of copies received: 1 on behalf of Plaintiff filed on 20-APR-2018

Affidavit of Nancy Gallinger sworn on 13-APR-2018 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 20 with Exhibits A to Q filed on 20-APR-2018

Letter from Plaintiff dated 19-APR-2018 Pursuant to the Order of the Court (Aylen, P) dated April 3, 2018, in advance of the CMC scheduled for April 23, 2018 received on 19-APR-2018

Affidavit of service of Nancy Gallinger sworn on 17-APR-2018 on behalf of Plaintiff confirming service of The Plaintiff's Motion (Protective Order) upon Defendant by email (electronically) on 17-APR-2018 filed on 17-APR-2018

Covering letter from Plaintiff dated 17-APR-2018 concerning Motion Record on behalf of the Plaintiffs placed on file on 17-APR-2018

Motion Record containing the following original document(s): 19 20 21 Number of copies received: 3 on behalf of Plaintiff filed on 17-APR-2018

Written Representations on behalf of Plaintiff concerning Motion Doc. No. 19 filed on 17-APR-2018

Affidavit of Nancy Gallinger sworn on 17-APR-2018 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 19 with Exhibits A-K filed on 17-APR-2018

Notice of Motion on behalf of Plaintiff returnable at Special Sitting in Ottawa on 30-APR-2018 to begin at 09:30 for an Order pursuant to section 5(3.7) of the Patented Medicines (Notice of Compliance Regulations) varying the Confidentiality Rules imposed by Pfizer Canada and other relief filed on 17-APR-2018

Letter from Defendant dated 19-APR-2018 In response to the Order of the Court (Aylen, P) dated April 19, 2018. (paragraphs 3, 4 and 8) Counsel confirms that they can not yet advise as to a revised proposed timetable. Counsel confirms they will endeavor to discuss with counsel for the Plaintiffs in advance of the CMC scheduled for Monday April 23, 2018 in order to update the Court and hopefully provide a revised schedule. Regardless counsel feels that the CMC is necessary absent an updated timetable to faciliate the progress of these actions. received on 19-APR-2018

Memorandum to file from Kathy Craigie dated 18-APR-2018 Letter from the Defendant, dated April 18, 2018 was sent to Court. The Court confirmed that counsel in Toronto are welcome to appear in person in Ottawa on April 30, 2018. Counsel was advised on todays date; a formal direction will not issue. TRIAL JA/Ottawa Courtrooms/Support IT and TOR was notified of the change. VC arrangements were cancelled. placed on file.

Letter from Defendant dated 18-APR-2018 requesting to appear in person at Ottawa (rather than VC from Toronto) for the motion fixed for April 30, 2018 received on 18-APR-2018

Acknowledgment of Receipt received from All parties with respect to direction of the Court (Aylen, P) dated April 18, 2018 placed on file on 18-APR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 19-APR-2018 directing that The Plaintiffs' motion addressing Pfizer's confidentiality rules and seeking a protective order shall be heard on April 30, 2018 in accordance with the timetable already established by the Court. placed on file on 18-APR-2018

Letter from Plaintiff dated 18-APR-2018 in response to Pfizer's letter dated April 17, 2018. Counsel submits it is most efficient to hear the motion for confidentiality rules and possible protective order on April 30, 2018. received on 18-APR-2018

Letter from Defendant dated 17-APR-2018 Counsel writes in response to the Order of the Court dated April 3, 2018 and the direction of the Court dates April 9, 2018. Counsel suggest that if the Court is to hear a motion for protective order rather than a motion to vary Pfizer's confidentiality rules, such motion be heard at a later date (rather than the April 30, 2018 date held for the motion to vary a parties confidentiality rules). received on 17-APR-2018

Affidavit of service of Nancy Gallinger sworn on 13-APR-2018 on behalf of Plaintiff confirming service of doc. no. 17 and ID#39 upon Defendant by email on consent on 13-APR-2018 filed on 13-APR-2018

Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 13-APR-2018

Motion Record in response to Motion Doc. No. 9 containing the following original document(s): 15 16 Number of copies received: 3 on behalf of Plaintiff filed on 13-APR-2018

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 9 filed on 13-APR-2018

Affidavit of Nancy Gallinger sworn on 13-APR-2018 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 9 with Exhibits A-Q filed on 13-APR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 10-APR-2018 directing that It would appear from the correspondence from the parties that further discussions need to occur regarding the potential amendment of the confidentiality rules imposed by the parties in relation to their respective documents. Accordingly, the parties shall continue their discussions with a view to reaching a resolution of these issues. In the event that either party determines that a motion to vary the confidentiality rules is required, any moving record shall be served and filed by April 17, 2018. Any responding record shall be served and filed by April 26, 2018. As set out in the Court¿s earlier Scheduling Order, any such motions shall be heard on April 30, 2018. In relation to the motions to strike, the Plaintiffs may file their responding motion records under seal and such records shall be treated by the Registry as confidential. The Plaintiffs shall file a public version of their motion records by no later than April 20, 2018." placed on file on 10-APR-2018

Letter from Plaintiff dated 10-APR-2018 requesting a direction from the Court that the Plaintiffs' responding motion records be filed under seal. received on 10-APR-2018

Letter from Defendant dated 09-APR-2018 Counsel writes in response to the letter on behalf of counsel for the Plaintiffs and in response to the Order of the Court (Aylen, P) dated April 3, 2018. received on 09-APR-2018

Letter from Plaintiff dated 09-APR-2018 Further to the Court's direction regarding the motion to vary Confidentiality Rules in these proceedings, tentativley scheduled to be heard on April 30, 2018 received on 09-APR-2018

Copy of Scheduling Order dated 03-APR-2018 placed on file on 04-APR-2018 Original filed on Court File No. T-401-18

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of doc id 29 upon Plaintiff by e-mail on consent on 04-APR-2018 filed on 04-APR-2018

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 04-APR-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of doc 12 upon Plaintiff by e-mail on consent on 03-APR-2018 filed on 03-APR-2018

Motion Record containing the following original document(s): 11 Number of copies received: 3 on behalf of Defendant filed on 03-APR-2018

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 9 filed on 03-APR-2018

Ottawa 29-MAR-2018 BEFORE Mandy Aylen, Prothonotary Language: E Before the Court: Pre-Hearing Conference Result of Hearing: Direction to follow held by way of Conference Call in chambers Duration per day: 28-MAR-2018 from 01:00 to 02:06 Courtroom : Judge's Chambers - Ottawa Court Registrar: Kathy Craigie Total Duration: 1h6min Appearances: Mr. Norman, Mr. Creber, Mr. Lussier 613 786 0140 representing Plaintiff Ms. Dureen, Mr. Sprigings, Ms. Hitchman 416 777 2273 representing Defendant Comments: DARS back up not used, at request of the Court Heard together with T-401-18. For complete set of minutes please refer to Volume 994 pages 487 to 496 of the Minutes of Hearing Book Minutes of Hearing entered in Vol. 995 page(s) 36 - 37 Abstract of Hearing placed on file

Letter from Plaintiff dated 27-MAR-2018 further to the Courts direction dated March 26, 2018. re: proposed timetable in advance of CMC fixed for March 28, 2018 received on 27-MAR-2018

Letter from Defendant dated 27-MAR-2018 Further to the Courts direction dated March 26, 2018. re: revised proposed timetables to be discussed at the CMC fixed for March 28, 2018. received on 27-MAR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 26-MAR-2018 directing that As the parties have indicated that they are only conducting their consultations regarding the proposed timetable for this proceeding today, the parties shall, by no later than 3:00 pm (Eastern) on March 27, 2018, provide the Court with a status update following their discussion and their respective revised proposed timetables to be discussed at the case management conference on March 28, 2018. placed on file on 26-MAR-2018

Solicitor's certificate of service on behalf of Meghan Dureen, counsel for the Defendant confirming service of Notice of motion to strike upon Plaintiff by e-mail (with consent) on 26-MAR-2018 filed on 23-MAR-2018

Notice of Motion on behalf of the Defendant, Pfizer Canada returnable (but no hearing date indicated at this time) for An order pursuant to Rule 221(a) of the Federal Courts Rules that the action be struck filed on 23-MAR-2018

Letter from Defendant dated 23-MAR-2018 Notices of Motions to stike the actions in Court Files T-402-18 and T-402-18 -counsel attaches notice of Motion and Certificate of Service received on 23-MAR-2018

Letter from Defendant dated 23-MAR-2018 Furhter to the Courts Direction of March 15, 2018 including a proposed timetable received on 23-MAR-2018

Letter from Plaintiffs, Hoffmann-La Roche dated 23-MAR-2018 furhter to the Courts direction dated March 15, 2018 Including their proposed timetable in T-401-18 and T-402-18 received on 23-MAR-2018

Affidavit of service of Nancy Gallinger sworn on 22-MAR-2018 on behalf of Plaintiff confirming service of doc. 7 upon Defendant by electronic service on 22-MAR-2018 filed on 22-MAR-2018

Reply on behalf of Plaintiff Filed on 22-MAR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 16-MAR-2018 directing that The Court is in receipt of correspondence from the Plaintiffs seeking to schedule a case management conference in these PMNOC actions, which would we held at the same time as the case management conferences currently scheduled in T-869-17, T-876-17, T-1269-17 and T-1270-17. The Court is not prepared to conduct a case management conference that will seek to set six timetables at the same time. As such, a case management conference a case management conference will be held on T-401-18 and T-402-18 on March 28, 2018 at 1:00 pm (Eastern). The case management conferences scheduled in T-869-17, T-876-17, T- 1269-17 and T-1270-17 on that date are adjourned. The parties shall, by no later than March 22, 2018, provide the Court with their availability for a case management conference in those other four actions that will be held on a date after the case management conference in the PMNOC actions. As the timetable in the PMNOC actions will have an impact on the timing of steps in the other four actions, the parties will need to consider the impact of the PMNOC actions timetable on their proposed timetables in the other four actions and shall provide the Court with revised proposed timetables in the other four actions by no later than three days before the re-scheduled case management conference. The correspondence from the Plaintiffs indicated that the parties will provide the Court with "an update and/or agenda in advance of the case management conference" for the PMNOC actions. This is not sufficient. The Court's Direction dated March 2, 2018 requires that the parties submit their jointly-proposed timetable in accordance with the template provided and indicate for each potential step in the proceeding whether it will apply to the proceeding and if so, the date for completion/filing in relation to each step. Accordingly, the parties shall jointly or absent an agreement, individually, provide the Court with a fully-completed timetable in relation to each applicable step of the proceeding as set out in the template by no later than March 23, 2018. placed on file on 16-MAR-2018

Letter from The Plaintiffs, Hoffman-La Rouche Limited dated 14-MAR-2018 re: CMC in this matter be combined with the CMC's already fixed in T-869-17, T-876-17, T-1269-17 and T-1270-17 (fixed for March 28, 2018) received on 14-MAR-2018

Solicitor's certificate of service on behalf of Meghan A. Dureen confirming service of doc 5 upon Plaintiff by e-mail on 12-MAR-2018 filed on 12-MAR-2018

Defence on behalf of Defendant filed on 12-MAR-2018

Affidavit of service of François DOyon sworn on 05-MAR-2018 on behalf of Plaintiff confirming service of doc. #1 upon Defendant by process server on 02-MAR-2018 filed on 09-MAR-2018

Consent on behalf of all parties to electronic service of all documents not required to be served personally; filed on 08-MAR-2018

Acknowledgment of Receipt received from 2 counsel/parties by fax on 06-MAR-2018 with respect to Order doc. 2 of the Chief Justice, dated 5-MAR-2018 placed on file on 06-MAR-2018

Order dated 05-MAR-2018 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Special Case Result: "IT IS ORDERED pursuant to Rule 383 that Prothonotary Mandy Aylen is assigned as Case Management Judge in this matter." Filed on 06-MAR-2018 certified copies sent to 2 counsel/parties by fax on 06-MAR-2018 Transmittal Letters placed on file. entered in J. & O. Book, volume 1362 page(s) 160 - 160 Interlocutory Decision

Acknowledgment of Receipt received from Plaintiff with respect to Direction of the Court Aylen, P dated March 2, 2018 placed on file on 02-MAR-2018

Oral directions received from the Court: Mandy Aylen, Prothonotary dated 02-MAR-2018 directing that As the Plaintiffs are aware, the Plaintiffs are required to requisition a case management conference and provide a jointly-proposed timetable of all steps leading up to trial and dates of mutual availability for trial within seven days of service of the Notice of Intentional to Respond. The Court requires that the parties submit their jointly-proposed timetable in accordance with the attached template and indicate for each potential step in the proceeding whether it will apply to the proceeding whether it will apply to the proceeding and if so, the date for completion/filing in relation to each step. As the Defendant has not yet filed a Notice of Intention to Respond, , the Plaintiffs shall provide the Defendant with a copy of this Direction and template forthwith upon being served with the Notice of Intention to Respond. placed on file on 02-MAR-2018

Communication to the Court from the Registry dated 02-MAR-2018 re: Sent to Judicial Administrator on 02-MAR-2018 - CMJ to be assigned - PMNOC.

Letter from Plaintiff dated 01-MAR-2018 informing the Court of four additional proceedings in the Federal Court, in which the Plaintiff's product is also involved, though with different parties than with previously cited proceedings. received on 01-MAR-2018

Copy of covering letter NOC proceeding, requesting that the proceeding be CM pursuant to Regulation 6.10(1) in accordance with Rules 383, 383.1 and 385 of FCR on behalf of Plaintiff placed on file on 01-MAR-2018 Original placed on Court File No. T-401-18

Statement of Claim filed on 01-MAR-2018 Tariff other action - $150.00